There’s no room for stagnation in life sciences. In an industry that demands innovation, pharmaceutical, biotechnology, and medical device companies are seeking quicker, cost-effective strategies to accelerate product development.
“The life sciences industry is experiencing astounding growth as companies race to make new discoveries and develop products that can improve lives and change the world.”
Cal McCarthy, Vice President, Life Sciences, Medix
The rising complexity of protocols and regulatory oversight is leading many companies to seek third-party expertise and support to keep clinical trials on track.
That support comes in all shapes, sizes, and strategies:
- CROs
- PROs
- SMOs
- BPOs
- CMOs
- Staffing firms and more
In our guide to clinical research outsourcing strategies, you’ll learn how these partnerships work and understand the key market drivers and constraints for each of these models.
